ATE414154T1 - Moraxella (branhamella) catarrhalis antigene - Google Patents
Moraxella (branhamella) catarrhalis antigeneInfo
- Publication number
- ATE414154T1 ATE414154T1 AT02729696T AT02729696T ATE414154T1 AT E414154 T1 ATE414154 T1 AT E414154T1 AT 02729696 T AT02729696 T AT 02729696T AT 02729696 T AT02729696 T AT 02729696T AT E414154 T1 ATE414154 T1 AT E414154T1
- Authority
- AT
- Austria
- Prior art keywords
- branhamella
- moraxella
- catarrhalis antigen
- catarrhalis
- antigen
- Prior art date
Links
- 241000588621 Moraxella Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29065301P | 2001-05-15 | 2001-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE414154T1 true ATE414154T1 (de) | 2008-11-15 |
Family
ID=23116982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02729696T ATE414154T1 (de) | 2001-05-15 | 2002-05-15 | Moraxella (branhamella) catarrhalis antigene |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7410645B2 (de) |
| EP (2) | EP1392831B1 (de) |
| JP (2) | JP2005500024A (de) |
| CN (2) | CN1514879A (de) |
| AT (1) | ATE414154T1 (de) |
| AU (1) | AU2002302236B2 (de) |
| CA (1) | CA2447017A1 (de) |
| DE (1) | DE60229845D1 (de) |
| ES (1) | ES2316563T3 (de) |
| WO (1) | WO2002092625A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010136562A2 (en) * | 2009-05-28 | 2010-12-02 | Intercell Ag | Moraxella catarrhalis antigens |
| CN110527740B (zh) * | 2019-09-11 | 2022-03-22 | 东北农业大学 | 一种与印度南瓜强雌基因紧密连锁的分子标记、引物及应用 |
| JP6964161B2 (ja) * | 2020-04-06 | 2021-11-10 | 旭化成株式会社 | 検体中のモラクセラ・カタラーリス菌を検出するための抗体、並びに斯かる抗体を用いてモラクセラ・カタラーリス菌を検出するための方法、試薬、及びキット |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
| US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| WO1994006421A1 (en) | 1992-09-16 | 1994-03-31 | The University Of Tennessee Research Corporation | Recombinant multivalent m protein vaccine |
| CA2123580C (en) | 1992-09-16 | 2005-04-26 | James B. Dale | Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| US6716433B1 (en) | 1997-09-12 | 2004-04-06 | University Of Tennessee Research Foundation | Group a streptococcal vaccines |
| EP1029052B1 (de) | 1997-11-06 | 2010-08-04 | Novartis Vaccines and Diagnostics S.r.l. | Neisseriale antigene |
| GB9810084D0 (en) | 1998-05-11 | 1998-07-08 | Cortecs Uk Ltd | Proteins |
| GB9817824D0 (en) | 1998-08-14 | 1998-10-14 | Smithkline Beecham Biolog | Novel compounds |
| US6673910B1 (en) * | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| EP1185658B1 (de) | 1999-05-24 | 2008-06-04 | GlaxoSmithKline Biologicals S.A. | Neue verbindungen aus moraxella catarrhalis |
| AU1824101A (en) * | 1999-06-18 | 2001-01-09 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
| GB9921691D0 (en) * | 1999-09-14 | 1999-11-17 | Smithkline Beecham Sa | Novel compounds |
| AU8743001A (en) * | 2000-08-28 | 2002-03-13 | Aventis Pasteur | Moraxella polypeptides and corresponding dna fragments and uses thereof |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
-
2002
- 2002-05-15 AT AT02729696T patent/ATE414154T1/de not_active IP Right Cessation
- 2002-05-15 ES ES02729696T patent/ES2316563T3/es not_active Expired - Lifetime
- 2002-05-15 WO PCT/CA2002/000706 patent/WO2002092625A2/en not_active Ceased
- 2002-05-15 US US10/477,592 patent/US7410645B2/en not_active Expired - Fee Related
- 2002-05-15 EP EP02729696A patent/EP1392831B1/de not_active Expired - Lifetime
- 2002-05-15 AU AU2002302236A patent/AU2002302236B2/en not_active Ceased
- 2002-05-15 EP EP08168688A patent/EP2025754A3/de not_active Withdrawn
- 2002-05-15 CA CA002447017A patent/CA2447017A1/en not_active Abandoned
- 2002-05-15 CN CNA028116895A patent/CN1514879A/zh active Pending
- 2002-05-15 CN CNA2007101028396A patent/CN101063141A/zh active Pending
- 2002-05-15 JP JP2002589508A patent/JP2005500024A/ja active Pending
- 2002-05-15 DE DE60229845T patent/DE60229845D1/de not_active Expired - Fee Related
-
2008
- 2008-05-13 JP JP2008126155A patent/JP2008289480A/ja active Pending
- 2008-07-15 US US12/173,390 patent/US20090074807A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1392831A2 (de) | 2004-03-03 |
| US20090074807A1 (en) | 2009-03-19 |
| EP2025754A2 (de) | 2009-02-18 |
| WO2002092625A3 (en) | 2003-07-10 |
| EP2025754A3 (de) | 2009-05-13 |
| ES2316563T3 (es) | 2009-04-16 |
| CN1514879A (zh) | 2004-07-21 |
| JP2008289480A (ja) | 2008-12-04 |
| WO2002092625A2 (en) | 2002-11-21 |
| US20040236087A1 (en) | 2004-11-25 |
| JP2005500024A (ja) | 2005-01-06 |
| AU2002302236B2 (en) | 2008-09-25 |
| CN101063141A (zh) | 2007-10-31 |
| CA2447017A1 (en) | 2002-11-21 |
| US7410645B2 (en) | 2008-08-12 |
| EP1392831B1 (de) | 2008-11-12 |
| DE60229845D1 (de) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE378403T1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
| CY1113224T1 (el) | Νεο αντισωμα αντι-ρlgf | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| IL189629A0 (en) | Compositions containing human ctla-4 antibodies | |
| CY1108387T1 (el) | Ανταγωνιστες ανασυνδυασμενης il-18 χρησιμοι στη θεραπεια παθησεων που εμφανιζονται με διαμεσολαβηση της il-18 | |
| DK2000545T3 (da) | Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor | |
| TR200200472T2 (tr) | Anti-Erb B2 antikorları ile tedavi için dozajlar | |
| DE60136054D1 (de) | Apoptose-induzierendes polypeptid | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
| DE60232862D1 (de) | Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus | |
| ATE477274T1 (de) | Gegen clostridium difficile gerichtete antikörper | |
| DE60140972D1 (de) | Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen | |
| BR0113099A (pt) | Gene e proteìna relacionados com esquizofrenia | |
| ATE414154T1 (de) | Moraxella (branhamella) catarrhalis antigene | |
| DE60335610D1 (de) | Neoplasma-spezifische antikörper und deren verwendungen | |
| ATE421586T1 (de) | Moraxella (branhamella) catarrhalis antigene | |
| DK1276495T3 (da) | Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme | |
| EA200600956A1 (ru) | Молекулы-антагонисты цитокинов | |
| TR200003345T2 (tr) | Moraxella Catarrhalıs'in bileşikleri | |
| DE69921649D1 (de) | Moraxella catarrhalis pilq proteine | |
| DE60229871D1 (de) | Moraxella (branhamella) catarrhalis polypeptide | |
| WO2003018052A8 (en) | Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments | |
| ATE293693T1 (de) | Moraxella catarrhalis antigen basb117 | |
| ATE293692T1 (de) | Moraxella catarrhalis antigen basb120 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |